| scholarly article | Q13442814 |
| P50 | author | Anthony Fauci | Q573246 |
| P2860 | cites work | Initial sequencing and analysis of the human genome | Q21045365 |
| The Sequence of the Human Genome | Q22065842 | ||
| Whole-genome random sequencing and assembly of Haemophilus influenzae Rd | Q27860765 | ||
| A molecular view of microbial diversity and the biosphere | Q28235782 | ||
| Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group | Q28241816 | ||
| Comparative genomics of the eukaryotes | Q29547504 | ||
| Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance | Q29615118 | ||
| Innate immunity | Q29618949 | ||
| Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how? | Q30326960 | ||
| Influenza: an emerging disease | Q30431321 | ||
| The promise of comparative genomics in mammals | Q33751818 | ||
| Pharmacogenomics. Interview by Clare Thompson | Q33821420 | ||
| Dengue and dengue hemorrhagic fever in Latin America and the Caribbean | Q33876198 | ||
| Changing patterns of infectious disease | Q34017357 | ||
| Microbial genome sequencing | Q34017372 | ||
| Are all diseases infectious? | Q34408047 | ||
| Infectious disease as an evolutionary paradigm | Q36890615 | ||
| Infectious causes of chronic inflammatory diseases and cancer | Q37092667 | ||
| Gay men report high rates of unprotected anal sex with partners of unknown or discordant HIV status | Q41687425 | ||
| Trends in infectious diseases mortality in the United States. | Q51036585 | ||
| Implications of the Human Genome Project for medical science. | Q52542147 | ||
| The Search for Unrecognized Pathogens | Q57180707 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | infectious diseases | Q788926 |
| P304 | page(s) | 675-685 | |
| P577 | publication date | 2001-03-01 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Infectious Diseases: Considerations for the 21st Century | |
| P478 | volume | 32 |
| Q35756736 | A comprehensive repertoire of prokaryotic species identified in human beings |
| Q36315079 | A microfluidic platform for real-time and in situ monitoring of virus infection process |
| Q44586521 | A new method for rapid identification of ansamycin compounds by inactivating KLM gene clusters in potential ansamycin-producing actinomyces |
| Q35615151 | Adjunctive dexamethasone treatment in acute bacterial meningitis |
| Q28390170 | Advocacy, promotion and e-learning: Supercourse for zoonosis |
| Q57297437 | Antibacterial and Antibiofilm Activity and Mode of Action of Magainin 2 against Drug-Resistant Acinetobacter baumannii |
| Q64929517 | Antimalarial activity of hydromethanolic extract and its solvent fractions of Vernonia amygdalina leaves in mice infected with Plasmodium berghei. |
| Q31115498 | Antimicrobial evaluation of nocathiacins, a thiazole peptide class of antibiotics |
| Q39264819 | Antimicrobial evaluation of the polyisoprenylated benzophenones nemorosone and guttiferone A. |
| Q36845880 | Antimicrobial stewardship: a review of prospective audit and feedback systems and an objective evaluation of outcomes |
| Q36261750 | Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice. |
| Q43850232 | Biological warfare, bioterrorism and public health |
| Q40308518 | Burden and spectrum of infectious disease in Germany 2009-2014: a multicentre study from Berlin's Municipal Hospitals |
| Q36795395 | Cardiac manifestations of parasitic infections part 1: overview and immunopathogenesis. |
| Q56772857 | Combating emerging infectious diseases in India: orchestrating a symphony |
| Q36159032 | Comparison of the functional features of the pump organs of Anopheles sinensis and Aedes togoi |
| Q91901162 | Considerations for infectious disease research and practice |
| Q37347385 | Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa |
| Q30832206 | Crossing the interspecies barrier: opening the door to zoonotic pathogens |
| Q99412906 | Cultural Competence and Humility in Infectious Diseases Clinical Practice and Research |
| Q47099854 | Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis. |
| Q58610002 | Dissecting human disease with single-cell omics: application in model systems and in the clinic |
| Q54258544 | EMERGING INFECTIOUS DISEASES - OVERVIEW. |
| Q42731688 | Efficacy of neutral and negatively charged liposome-loaded gentamicin on planktonic bacteria and biofilm communities. |
| Q26864828 | Emerging & re-emerging infections in India: an overview |
| Q42365856 | Emerging and Re-emerging Infectious Diseases in South East Asia |
| Q37670961 | Emerging and re-emerging infections at the turn of the millennium |
| Q27489050 | Emerging and re-emerging viruses in the era of globalisation |
| Q28383084 | Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases |
| Q57926982 | Equity and determinants of routine child immunisation programme among tribal and non-tribal populations in rural Tangail subdistrict, Bangladesh: a cohort study |
| Q30416280 | Evolutionary dynamics of HIV at multiple spatial and temporal scales. |
| Q36826961 | Expression and function of psoriasin (S100A7) and koebnerisin (S100A15) in the brain |
| Q33225644 | Expression library immunization: a road map for discovery of vaccines against infectious diseases |
| Q33186164 | Fever of unknown origin in adults: 40 years on. |
| Q26774211 | Fighting the Monster: Applying the Host Damage Framework to Human Central Nervous System Infections |
| Q36906327 | Global infections--avian influenza and other significant emerging pathogens: an overview |
| Q42237763 | Global infectious diseases - the new norm for the United States? |
| Q90668040 | Global stressors and the global decline of amphibians: tipping the stress immunocompetency axis |
| Q36701462 | In vitro antimicrobial activity of extracts from plants used traditionally in South Africa to treat tuberculosis and related symptoms |
| Q51100473 | In vitro studies on the release of isoniazid incorporated in poly(epsilon-caprolactone). |
| Q28087766 | Infectious disease transmission and contact networks in wildlife and livestock |
| Q30978178 | Intracellular expression of Peptide fusions for demonstration of protein essentiality in bacteria. |
| Q36126206 | Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice |
| Q54430510 | Involvement of Escherichia coli K1 ibeT in bacterial adhesion that is associated with the entry into human brain microvascular endothelial cells. |
| Q30379449 | Isolation rooms for highly infectious diseases: an inventory of capabilities in European countries. |
| Q37909413 | Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs. |
| Q56794115 | La asistencia infectológica actual en España |
| Q35128642 | Lamivudine/zidovudine/abacavir: triple combination tablet |
| Q48327489 | Lasker Public Service Award. The expanding global health agenda: a welcome development |
| Q35213941 | Link removal for the control of stochastically evolving epidemics over networks: a comparison of approaches |
| Q34407240 | Methicillin-resistant Staphylococcus aureus: a pervasive pathogen highlights the need for new antimicrobial development. |
| Q43291849 | Microencapsulation of isoniazid in genipin-crosslinked gelatin-A-κ-carrageenan polyelectrolyte complex |
| Q34551506 | Microfluidic diagnostic technologies for global public health |
| Q33712087 | Modeling the Cost-Effectiveness of the Integrated Disease Surveillance and Response (IDSR) System: Meningitis in Burkina Faso |
| Q38167600 | Nanosilver-based antibacterial drugs and devices: mechanisms, methodological drawbacks, and guidelines |
| Q98830964 | Nanotechnological strategies for systemic microbial infections treatment: A review |
| Q37293213 | Natural Mosquito-Pathogen Hybrid IgG4 Antibodies in Vector-Borne Diseases: A Hypothesis |
| Q92150844 | New and Potent Quinuclidine-Based Antimicrobial Agents |
| Q44190399 | New hope for biomarkers in the practice of infectious diseases medicine |
| Q37525450 | Nosocomial or hospital-acquired infections: an overview |
| Q47349591 | Nucleic acid aptamer-based methods for diagnosis of infections |
| Q43172000 | Nurses' perceptions of risk from emerging respiratory infectious diseases: a Singapore study |
| Q36124734 | Oligonucleotides and polyribonucleotides: a review of antiviral activity |
| Q36998858 | On the exoneration of Dr. William H. Stewart: debunking an urban legend |
| Q36159045 | On-chip Extraction of Intracellular Molecules in White Blood Cells from Whole Blood |
| Q35120141 | Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury |
| Q98178429 | Pediatric Hearing Thresholds Post-bacterial Meningitis |
| Q60935453 | Peptide Extract from Olivancillaria hiatula Exhibits Broad-Spectrum Antibacterial Activity |
| Q40435544 | Peptide inhibitors of the essential cell division protein FtsA. |
| Q53271413 | Postgraduate training in infectious diseases: investigating the current status in the international community. |
| Q28743065 | Projections of global health outcomes from 2005 to 2060 using the International Futures integrated forecasting model |
| Q28083679 | Recent advances of vaccine adjuvants for infectious diseases |
| Q38810357 | Recent trends on hydrogel based drug delivery systems for infectious diseases |
| Q58573884 | Resistance trends and in vitro activity of tigecycline and 17 other antimicrobial agents against Gram-positive and Gram-negative organisms, including multidrug-resistant pathogens, in Germany |
| Q36683498 | Resistance-Nodulation-Division Multidrug Efflux Pumps in Gram-Negative Bacteria: Role in Virulence |
| Q38939434 | Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery |
| Q27023304 | Right or left: the role of nanoparticles in pulmonary diseases |
| Q88600737 | SELECTED EPIDEMICS & EMERGING PATHOGENS |
| Q73355144 | Severe Acute Respiratory Syndrome. A new emergent infectious disease |
| Q37359451 | Specific interactions of clausin, a new lantibiotic, with lipid precursors of the bacterial cell wall |
| Q36683640 | Synthesis, Antibacterial Evaluation and QSAR of α-Substituted-N₄-Acetamides of Ciprofloxacin and Norfloxacin |
| Q38063490 | Systems biology of pathogen-host interaction: networks of protein-protein interaction within pathogens and pathogen-human interactions in the post-genomic era. |
| Q46099473 | Targeted delivery of levofloxacin-liposomes for the treatment of pulmonary inflammation |
| Q33886389 | The HIV oligonucleotide database (HIVoligoDB). |
| Q29617354 | The challenge of emerging and re-emerging infectious diseases |
| Q27008860 | The changing face of pathogen discovery and surveillance |
| Q46023519 | The evolving role of infectomics in drug discovery. |
| Q84720883 | The medical literature and the discipline of infection control |
| Q27487189 | Western Equine Encephalitis submergence: Lack of evidence for a decline in virus virulence |
Search more.